Trial Site Detail
Drug: |
Imatinib + Sunitinib + Regorafenib |
|||
|---|---|---|---|---|
Trial: |
GIST: Assessment of Tumor Mutations and TKI Plasma Exposure |
|||
| Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Recruiting |
|||
Erasmus Medical center's-Gravendijkwal 230 |
Principal Investigator: |
R. H. Mathijssen, MD, PhD |
|---|---|
Contact: |
a.mathijssen@erasmusmc.nl |
Activation Status of this Site: |
Not yet activated |
Notes about this Site: |
|
Erasmus Medical center Website: |
Navigating the Map
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.